Efficacy and immune-related adverse events of pembrolizumab with bone-modifying agents in female patients with breast cancer

Zhou M, Velez LM, Kwan D, Moses L, Johnson CD, Nguyen CM, Mott L, Gamie F, Fouladi M, Bae H, Verlande A, Arneson D, Petrus[...]

Cleveland S, Carroll JE, Montoya AK, Cha L, Stiles L, Sumner JA. Early Life Adversity and Mitochondrial Function: Comparing Cumulative Risk and Dimensional Models of[...]

Clair K, Fletcher EH, Oishi A, Schweizer CA, Jackson L, Chanfreau C, Finley EP, Hamilton A, Moin T, Farmer MM, Bean-Mayberry B. "It's Just a[...]